<研究開発・メディカルアフェアーズ統括本部>project Statistician/ Principal Statistician /kobe Hq・tokyo

Eli Lilly Eli Lilly · Pharma · Kobe, Japan

This role focuses on providing statistical leadership in drug development, including clinical trial design, data analysis, and real-world evidence research for healthcare products. It involves collaborating with physicians and medical colleagues, developing protocols, and communicating results for regulatory submissions and publications. The role requires an M.S. or Ph.D. in statistics or biostatistics and offers opportunities in Kobe or Tokyo.

What you'd actually do

  1. Provide strong statistical leadership in the process of drug development.
  2. Provide input and statistical leadership for post launch activities including Health technology assessment (HTA), real world evidence (RWE) research, post-market safety studies, medical affairs publications to maximize the value of our products in collaboration with cross-functional and cross-regional partners.
  3. Operate in collaboration with study personnel to provide input on study protocol, design studies and write protocols for the conduct of each study.
  4. Assist in or be accountable for selecting statistical methods for data analysis, authoring the corresponding sections of the protocol, and conducting the actual analysis once a reporting database is created.
  5. Collaborate with data management in the planning and implementation of data quality assurance plans.

Skills

Required

  • M.S. or Ph.D. in statistics or biostatistics
  • Statistical trial design
  • Data analysis
  • Clinical development
  • Epidemiology
  • Regulatory knowledge of clinical trial methodology and statistics

Nice to have

  • Real world evidence research
  • Health technology assessment (HTA)
  • Network meta-analysis
  • Economic modelling
  • Dossier development
  • English and Japanese communication and presentation skills

What the JD emphasized

  • M.S. or Ph.D. in statistics or biostatistics
  • Statistical and methodological knowledge in clinical development, epidemiology or related field.
  • Regulatory knowledge of clinical trial methodology and statistics.